Publications by authors named "Guido Bisping"

Claim this Profile
P
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Martin Kirschner, Nicole do Ó Hartmann, Stefani Parmentier, Christina Hart, Larissa Henze, Guido Bisping

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study.
Martin Kropff, Martin Vogel, Guido Bisping, Rudolf Schlag, Rudolf Weide

Ann Hematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis.
Axel Matzdorff, Hanno Riess, Frauke Bergmann, Guido Bisping, Steffen Koschmieder

Oncol Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).
Iris Appelmann, Stephan Kreher, Stefani Parmentier, Hans-Heinrich Wolf, Guido Bisping

Ann Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria.
Emile Rijcken, Soeren Torge Mees, Guido Bisping, Kristin Krueger, Matthias Bruewer

Int J Surg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minireview: Malassezia infections in immunocompromised patients.
Athanasios Tragiannidis, Guido Bisping, Gabriele Koehler, Andreas H Groll

Mycoses· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
Michele Pohlen, Bülent Sargin, Stefan Zicholl, Guido Bisping, Carsten Müller-Tidow

Eur J Haematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.
Martin Kropff, Joachim Kienast, Guido Bisping, Wolfgang E Berdel, Birgit Gaschler-Markefski

Anticancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Silke Landmeier, Bianca Altvater, Sibylle Pscherer, Heribert Juergens, Lena Varnholt, Guido Bisping

J Immunother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
Guido Bisping, Doris Wenning, Martin Kropff, Dirk Gustavus, Carsten Müller-Tidow

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells.
Niels Reinmuth, Sonja Rensinghoff, Miriam Raedel, Nicole Fehrmann, Christian Schwöppe, Guido Bisping

Int J Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
Martin Kropff, Guido Bisping, Elke Schuck, Peter Liebisch, Nicola Lang

Br J Haematol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
Matthias Stelljes, Christiane Specht, Jörn Albring, Sarah Volkmann, Verena Schlösser, Guido Bisping

Transplantation· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors.
Emma Kulimova, Elisabeth Oelmann, Guido Bisping, Joachim Kienast, Rolf M Mesters

Mol Cancer Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition in multiple myeloma.
Martin Kropff, Guido Bisping, Doris Wenning, Wolfgang E Berdel, Joachim Kienast

Eur J Cancer· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
Guido Bisping, Martin Kropff, Doris Wenning, Britta Dreyer, Sergey Bessonov

Blood· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib in combination with dexamethasone for relapsed multiple myeloma.
Martin H Kropff, Guido Bisping, Doris Wenning, Sarah Volpert, Joëlle Tchinda

Leuk Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.
Matthias Stelljes, Robert Strothotte, Hans-Gerd Pauels, Christopher Poremba, Michaela Milse, Guido Bisping

Blood· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma.
Martin H Kropff, Nicola Lang, Guido Bisping, Nicole Dominé, Georg Innig

Br J Haematol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
Guido Bisping, Regine Leo, Doris Wenning, Berno Dankbar, Teresa Padró

Blood· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis